Published in J Immunol on April 01, 1979
Stimulation of Ca2+-dependent chemiluminescence in rat polymorphonuclear leucocytes by polystyrene beads and the non-lytic action of complement. Immunology (1981) 1.79
Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins. J Clin Invest (1983) 1.12
Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells. Agents Actions (1986) 0.82
Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement. J Immunol (1967) 8.06
Complement fixation on cell surfaces by 19S and 7S antibodies. Science (1965) 4.04
Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry (1973) 4.00
Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte. J Immunol (1965) 3.42
Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol (1982) 3.28
Complement and Hemolysis. Science (1963) 2.73
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
BCG and cancer (first of two parts). N Engl J Med (1974) 2.13
Role of serology in the diagnosis of Lyme disease. JAMA (1999) 2.11
Forssman antigen and antibody: preparation of water soluble antigen and measurement of antibody concentration by precipitin analysis, by C'1a fixation and by hemolytic activity. J Immunol (1966) 1.95
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody. J Immunol (1966) 1.80
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol (1994) 1.76
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
BCG and cancer. N Engl J Med (1974) 1.66
Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A (1970) 1.63
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4. J Immunol (1971) 1.60
Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst (1971) 1.46
Synthesis of the first component of human complement in vitro. J Exp Med (1968) 1.44
Production of the second (C2) and fourth (C4) components of guinea pig complement by single peritoneal cells: evidence that one cell may produce both components. J Immunol (1972) 1.44
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem (1991) 1.38
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
In vitro synthesis of the first component of complement by guinea pig small intestine. Proc Natl Acad Sci U S A (1966) 1.30
Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant. J Natl Cancer Inst (1968) 1.28
Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. J Natl Cancer Inst (1970) 1.27
Mouse complement: the effect of sex hormones and castration on two of the late-acting components. J Exp Med (1967) 1.26
Purification of the first component of complement by zonal ultracentrifugation. J Immunol (1969) 1.26
The C'la fixation and transfer test: examples of its applicability to the detection and enumeration of antigens and antibodies at cell surfaces. J Immunol (1968) 1.25
Aflatoxin B; specific antibodies and their use in radioimmunoassay. J Natl Cancer Inst (1976) 1.25
Applications of immobilized protein A in immunochemical techniques. J Immunol Methods (1982) 1.22
Neutralization of sensitized virus by the fourth component of complement. Science (1969) 1.21
Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus. Microb Pathog (1988) 1.20
Synthesis of the first component of guinea pig complement by columnar epithelial cells of the small intestine. J Immunol (1968) 1.19
Isolation and characterization of type IIa and type IIb Fc receptors from a group A streptococcus. Scand J Immunol (1986) 1.18
125I-Labeled protein A: reactivity with IgG and use as a tracer in radioimmunoassay. Methods Enzymol (1980) 1.17
Synthesis of the second component of guinea pig complement in vitro. J Immunol (1971) 1.16
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis (1992) 1.15
Immunotherapy of an intramuscular tumor in strain-2 guinea pigs: prevention of tumor growth by intradermal immunization and by systemic transfer of tumor immunity. J Natl Cancer Inst (1970) 1.14
Tumor-specific antigens detected by inhibition of macrophage migration. Science (1969) 1.13
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun (1989) 1.12
Stereospecific monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. J Immunol Methods (1986) 1.12
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
Radioimmunoassay for nicotine and cotinine. IARC Sci Publ (1987) 1.11
125I protein A: applications to the quantitative determination of fluid phase and cell-bound IgG. J Immunol Methods (1977) 1.10
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size. J Immunol (1979) 1.09
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis (1988) 1.07
Measurement of leukocyte chemotaxis in vivo. Methods Enzymol (1988) 1.07
Isolation and partial characterization of a type II Fc receptor from a group A streptococcus. Mol Cell Biochem (1986) 1.07
Detection of bound C3 by a new immunochemical methods. J Immunol (1971) 1.06
Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J Immunol (1984) 1.06
Titration of the first component of complement on a molecular basis: suitability of IgM and unsuitability of IgG hemolysins as sensitizer. Immunochemistry (1969) 1.06
Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci. J Immunol (1991) 1.05
Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis (1991) 1.04
Quantitation of continine in sera of smokers. Res Commun Chem Pathol Pharmacol (1975) 1.04
Heterogeneity of rabbit IgM antibody as detected by C'1a fixation. J Exp Med (1968) 1.04
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun (1989) 1.02
Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol (1978) 1.02
Radioiodination by use of the Bolton-Hunter and related reagents. Methods Enzymol (1980) 1.01
Radioimmunoassay of nicotine, cotinine, and gamma-(3-pyridyl)-gamma-oxo-N-methylbutyramide. Methods Enzymol (1982) 1.00
Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma. J Natl Cancer Inst (1973) 1.00
Nicotine: cotinine levels in blood during cessation of smoking. Compr Psychiatry (1977) 1.00
Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis (1999) 0.99
Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis (1996) 0.99
Cotinine analytical workshop report: consideration of analytical methods for determining cotinine in human body fluids as a measure of passive exposure to tobacco smoke. Environ Health Perspect (1990) 0.99
Detection of receptors for the Fc region of IgG on streptococci. J Immunol Methods (1983) 0.99
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Identification of a unique receptor on a group A streptococcus for the Fc region of human IgG3. J Immunol (1986) 0.98
Immunotherapy of cancer: an experimental model in syngeneic guinea pigs. Science (1970) 0.98
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis (1995) 0.98
The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods (2000) 0.98
Efficiency of the first component of complement (C'1) in the hemolytic reaction. Science (1967) 0.98
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. II. Clustering of effective C42 complexes at individual hemolytic sites. J Immunol (1971) 0.97
Isoelectric focusing of human and guinea-pig C2: polymorphism of guinea-pig C2. Immunology (1970) 0.97
Detection of antigens of a new diethylnitrosamine-induced transplantable hepatoma by delayed hypersensitivity. J Natl Cancer Inst (1968) 0.97
A group A streptococcal Enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol (1994) 0.97
[125I]protein A: a tracer for general use in immunoassay. J Immunol Methods (1978) 0.97
Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog (1995) 0.97
Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid. J Immunol (1978) 0.96
Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol (1979) 0.96
Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1985) 0.96
Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between protein A and IgG. J Immunol (1978) 0.96
Cold-reacting antibodies: the enhancement of antibody fixation by the first component of complement (C'1a). J Immunol (1968) 0.96